At the 43rd Annual 2026 Miami Breast Cancer Conference, held from March 5-8th, experts highlighted several important advances in metastatic breast cancer care. In addition to scientific sessions for clinicians, the conference also included a dedicated program for patients and advocates through the CURE® Educated Patient® Breast Cancer Summit. This patient focused event brought together people living with breast cancer, caregivers, advocates, and leading clinicians for plain language discussions about current research, treatment options, quality of life issues, and clinical trials.
Visit the links below to explore some of the topics covered at this meeting for people with MBC.
- Treating Metastatic Breast Cancer While Pregnant: Jonise’s Story
- Treating Metastatic TNBC: Dr. Hope Rugo on ADCs and Personalized Therapy
- Oncolive: A Treatment called Trastuzumab Deruxtecan (T-DXd) is Helping People with HER2-low Metastatic Breast Cancer
- Oncolive: Shorter Radiation Therapy Schedules Show Promise for Advanced Breast Cancer
- Oncolive: A Combination of Zovegalisib and Fulvestrant is Helping Control Cancer for a Longer Time in People with PIK3CA-Mutated, HR-Positive, HER2-Negative Advanced Breast Cancer
- Oncolive: Patients with Advanced Triple Negative Breast Cancer Showed Tumor Responses when Treated with Dato DXd plus Durvalumab
- Metastatic Trial Search: Trials enrolling people with HER2 Low MBC
- Metastatic Trial Search: MBC Trials for HR-Positive, HER2-Negative with PIK3CA Mutation
- Metastatic Trial Search: Trials specifically for people with triple-negative MBC
- Metastatic Trial Search: Trials enrolling people with triple-negative MBC
- Metastatic Trial Search: All MBC Trials That Include ADCs